Syndax Pharmaceuticals Inc (SNDX): Shares Outstanding
87.41M
As of 2025-12-31
89.15M
As of 2026-06-30
+8.7%
3-year compound annual growth
+12.8%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 87.41M | +2.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 85.69M | +1.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 84.83M | +24.5% | 2025-03-03, Balance as of period end |
| 2022-12-31 | 68.11M | +23.9% | 2024-02-27, Balance as of period end |
| 2021-12-31 | 54.98M | +14.8% | 2023-02-28, Balance as of period end |
| 2020-12-31 | 47.88M | +76.4% | 2022-03-01, Balance as of period end |
| 2019-12-31 | 27.14M | +9.3% | 2021-03-12, Balance as of period end |
| 2018-12-31 | 24.84M | +1.8% | 2020-03-05, Balance as of period end |
| 2017-12-31 | 24.39M | +33.9% | 2019-03-07, Balance as of period end |
| 2016-12-31 | 18.22M | n/m | 2018-03-08, Balance as of period end |
| 2015-12-31 | 85.4K | n/a | 2017-03-14, Balance as of period end |